Idexx Laboratories | IDXX - Current Assets


Idexx Laboratories reported $1.45B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
Align Technology USD 2.66B 38.87M Mar/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
Dentsply International USD 1.85B 178M Mar/2026
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Fujifilm JPY 1.72T 2.2B Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Henry Schein USD 4.5B 32M Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
Masimo USD 870.5M 55.5M Mar/2026
Neogen USD 590M 15.42M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Steris USD 2.39B 108.4M Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Zoetis USD 6.47B 294M Mar/2026